July 28, 2006Alpharma Inc • March 1st, 2007 • Pharmaceutical preparations
Alpharma Inc. Alpharma Operating Corporation Alpharma U.S. Inc. Barre Parent Corporation Alpharma Euro Holdings Inc. Alpharma (Bermuda) Inc. Alpharma USHP Inc. Alpharma Animal Health Company Mikjan Corporation Alpharma Holdings Inc. Alpharma Pharmaceuticals Inc. Purepac Pharmaceutical Holdings, Inc. Alpharma Branded Products Division Inc. Alpharma Investment Inc. One Executive Drive Fort Lee, New Jersey 07024
AGREEMENT ON THE SUCCESSION OF PENSION OBLIGATIONSAgreement • March 1st, 2007 • Alpharma Inc • Pharmaceutical preparations
AMENDMENT AGREEMENTAmendment Agreement • March 1st, 2007 • Alpharma Inc • Pharmaceutical preparations
THIS AMENDMENT AGREEMENT is made as of the 3rd day of December, 2006 between ALPHARMA BRANDED PRODUCTS DIVISION INC., a Delaware corporation ("Alpharma") and Actavis Elizabeth LLC. a Delaware limited liability corporation ("Actavis"). Actavis is the successor in interest to Purepac Pharmaceutical Co. (Alpharma and Actavis are each individually a "Party" and collectively the "Parties").
October 6, 2006Alpharma Inc • March 1st, 2007 • Pharmaceutical preparations
Reference is made to that certain Amended and Restated Loan and Security Agreement dated March 10, 2006 (as at any time amended, the "Loan Agreement"), among Alpharma Inc., a Delaware corporation, Alpharma Operating Corporation, a Delaware corporation, Alpharma U.S. Inc., a Delaware corporation, Alpharma Euro Holdings Inc., a Delaware corporation, Alpharma (Bermuda) Inc., a Delaware corporation, Alpharma USHP Inc., a Delaware corporation, Alpharma Animal Health Company, a Texas corporation, Mikjan Corporation, an Arkansas corporation, Alpharma Holdings Inc., a Delaware corporation, Alpharma Pharmaceuticals Inc., a Delaware corporation, Purepac Pharmaceutical Holdings, Inc., a Delaware corporation, Alpharma Branded Products Division Inc., a Delaware corporation, Barre Parent Corporation, a Delaware corporation, and Alpharma Investment Inc., a Delaware corporation (collectively, "Borrowers"), the various financial institutions party thereto from time to time (collectively, "Lenders") and
October 2, 2006Alpharma Inc • March 1st, 2007 • Pharmaceutical preparations
The following terms relate to a settlement of your employment at Alpharma Inc. and are offered for your consideration. For the purposes of this letter, you are referred to as the "Executive" and Alpharma Inc., and each of its subsidiaries and affiliates, are referred to as the "Company".
